ARCHIVES

Chemoprevention Concept Approved By DCPC Bard Uses Biological Markers To Assess Risk Modulation

This article is from The Cancer Letter archive.

Vol. 11 No. 37 | September 27, 1985

Download PDF Visit The Full Archive

Related Articles

Herceptin Reduces Recurrence In Early HER2+ Breast Cancer

September 30, 2005

NCI Gets 41.258 Bil. In Final FY 1986 Appropriations

November 29, 1985

In Brief: Job Discrimination Survey Report Not Ready Until Next Month; Saccharin Date Extended

September 17, 1977

NCI Advisors Set SPORE Review Criteria, Approve Plan To Fund New Ovarian Grant

June 26, 1998

Letter: Palestinian Authority Not Yet A Country

June 14, 1996

New Screening Tool Helps GP ID Hereditary BC Risk

October 27, 2006